Fundraising Fox

Jake Bauer

Investor

Venture Partner at SR One Capital Management

San Francisco Bay Area

About

Jake Bauer is a Venture Partner at SR One who works with emerging clinical biotechnology companies. He previously served as Chief Business Officer of MyoKardia, which was acquired by Bristol Myers Squibb in 2020, and held earlier roles at Ablexis, Third Rock Ventures, Royalty Pharma, Endo Pharmaceuticals, and Putnam Associates. He holds a BS in Biology and BA in Economics from Duke University and an MBA from Harvard Business School.

Invests in

Biotech

Investments

Board seats

Arya Sciences Acquisition Corp VAttralusEnliven TherapeuticsPhoenix Tissue Repair, Inc.

Per the firm's website.

Colleagues at SR One Capital Management